Haemonetics Corporation (HAE) Total liabilities 2017–2026
Haemonetics Corporation (HAE) total liabilities at each fiscal year-end, per SEC filings.
$1.6BFY2026 · since FY2017: $499.1M → $1.6B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | $1.6B | -1.9% |
| FY2025 | $1.6B | +31.9% |
| FY2024 | $1.2B | +10.6% |
| FY2023 | $1.1B | +0.6% |
| FY2022 | $1.1B | +2.0% |
| FY2021 | $1.1B | +60.0% |
| FY2020 | $680.0M | +12.0% |
| FY2019 | $606.9M | +25.2% |
| FY2018 | $484.9M | -2.8% |
| FY2017 | $499.1M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice